BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38781873)

  • 1. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
    Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
    Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19.
    Huang C; Hu X; Wang D; Gong R; Wang Q; Ren F; Wu Y; Chen J; Xiong X; Li H; Wang Q; Long G; Zhang D; Han Y
    Sci Rep; 2024 May; 14(1):10324. PubMed ID: 38710800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
    Wang YC; Tsai CH; Wang YC; Yen LC; Chang YW; Sun JR; Lin TY; Chiu CH; Chao YC; Chang FY
    Infection; 2024 Jun; 52(3):955-983. PubMed ID: 38133713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
    Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
    PeerJ; 2024; 12():e17257. PubMed ID: 38646483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
    Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
    J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Signature Associated With Disease Severity in COVID-19.
    Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
    Front Immunol; 2021; 12():681516. PubMed ID: 34489933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients.
    Ashrafzadeh-Kian S; Campbell MR; Jara Aguirre JC; Walsh J; Kumanovics A; Jenkinson G; Rinaldo P; Snyder MR; Algeciras-Schimnich A
    Cytokine; 2022 Feb; 150():155790. PubMed ID: 34991059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
    Peart Akindele N; Kouo T; Karaba AH; Gordon O; Fenstermacher KZJ; Beaudry J; Rubens JH; Atik CC; Zhou W; Ji H; Tao X; Vaidya D; Mostafa H; Caturegli P; Blair PW; Sauer L; Cox AL; Persaud D
    J Infect Dis; 2021 Aug; 224(4):606-615. PubMed ID: 34398245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.